Damage and repair of nerve cell DNA in toxic stress

Drug Metabolism Reviews

Volumn 31, Issue 3, 1999, Pages 589-618

  Kisby, Glen E ^a,b   Kabel, Hans ^a   Hugon, Jacques ^c   Spencer, Peter ^a,b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c UNIVERSITY OF LIMOGES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; METHYLAZOXYMETHANOL GLUCOSIDE; NEUROTOXIN; PLANT TOXIN;

ADULT; ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL MODEL; ANIMAL TISSUE; BRAIN TISSUE; CASE REPORT; CONFERENCE PAPER; CONTROLLED STUDY; DEGENERATIVE DISEASE; DEMENTIA; DNA REPAIR; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; MALE; MOTOR NEURON DISEASE; NERVE CELL DEGENERATION; NEUROLOGIC DISEASE; NEUROPATHOLOGY; NEUROTOXICITY; NONHUMAN; PARKINSONISM;

ANIMALS; CARCINOGENS; DNA DAMAGE; DNA REPAIR; GENE EXPRESSION; GYMNOSPERMS; HUMANS; METHYLAZOXYMETHANOL ACETATE; NEURODEGENERATIVE DISEASES; STRESS;

EID: 0032776086     PISSN: 03602532     EISSN: None     Source Type: Journal    
DOI: 10.1081/DMR-100101937     Document Type: Conference Paper

References (149)

1. R. M. Garruto and Y. Yase, Neurodegenerative disorders of the western Pacific: The search for mechanisms of pathogenesis, Trends Neurosci., 9, 368-375 (1986).
2. A. Hirano, N. Malamud, and L. T. Kurland, Parkinsonism-dementia complex, an endemic disease on the island of Guam. II. Pathological features, Brain, 84, 622-679 (1958).
3. L. T. Kurland and C. A. Molgaard, Guamanian ALS: Hereditary or acquired? in Human Motor Neuron Diseases (L. P. Rowland, ed.), Raven Press, New York, 1982.
4. R. Stone, Guam: Deadly disease dying out, Science, 261, 424-426 (1994).
5. R. M. Garruto and R. Yanagihara, Disappearance of high-incidence amyotrophic lateral sclerosis and parkinsonism-dementia on Guam, Neurology, 35, 193-198 (1985).
6. R. M. Garruto, R. Yanagihara, D. C. Gadjusek, and D. M. Arion, Concentrations of heavy metals and essential minerals in garden soil and drinking water in the Western Pacific, in Amyotrophic Lateral Sclerosis in Asia and Oceana (I. Chen and Y. Yase, eds.), National University, Taiwan, 1984.
7. P. S. Spencer, M. Ohta, and V. Palmer, Cycad use and motor neuron disease in Ku peninsula of Japan, Lancet, 2, 1462-1463 (1987).
8. P. S. Spencer, V. Palmer, A. Herman, and A. Asmedi, Cycad use and motor neuron disease in Irian Jaya, Lancet, 2, 1273-1274 (1987).
9. D. A. Figlewicz, R. M. Garruto, A. Krizus, R. Yanagihara, and G. A. Rouleau, The Cu/Zn superoxide dismutase gene in ALS and Parkinsonism-dementia of Guam, NeuroReport, 5, 557-560 (1994).
10. D. C. Gadjusek and A. M. Salazar, Amyotrophic lateral sclerosis and parkinsonian syndromes in high incidence among the Auyu and Jakai people of West New Guinea, Neurology, 32, 107-126 (1982).
11. C. J. Gibbs and D. C. Gadjusek, An update on long-term in vivo and in vitro studies designed to identify a virus as the cause of amyotrophic lateral sclerosis, parkinsonism-dementia, and Parkinson's disease, in Human Motor Neuron Diseases (L. P. Rowland, ed.), Raven Press, New York, 1982.
12. K.-M. Chen and Y. Yase, Parkinsonism-dementia, neurofibrillary tangles, and trace elements in the western Pacific, in Senile Dementia of the Alzheimer Type (J. T. Hutlon and A. D. Kenny, eds.), Alan R. Liss, Inc., New York, 1985.
13. J. E. Ahlskog, S. C. Waring, L. T. Kurland, R. C. Petersen, T. P. Moyer, W. S. Maraganore, P. C. O'Brien, C. Esteban-Santillan, and V. Bush, Guamanian neurodegenerative disease: Investigation of the calcium metabolism/heavy metal hypothesis, Neurology, 45, 1340-1344 (1995).
14. D. Perl, D. C. Gadjusek, and R. M. Garruto, Intraneuronal aluminum accumulation in amyotrophic lateral sclerosis and Parkinsonism-dementia on Guam, Science, 217, 1053-1055 (1982).
15. P. S. Spencer, S. M. Ross, G. Kisby, and D. N. Roy, Western Pacific amyotrophic lateral sclerosis: Putative role of cycad toxins, in Amyotrophic Lateral Sclerosis: Concepts in Pathogenesis and Etiology (A. J. Hudson, ed.), University of Toronto Press, Toronto, 1990.
16. P. S. Spencer, C. A. Allen, G. E. Kisby, and A. C. Ludolph, On the etiology and pathogenesis of chemically induced neurodegenerative disorders, Neurobiol. Aging, 15, 265-267 (1994).
17. D. Reed, D. Labarthe, K. M. Chen, and R. Stallones, A cohort study of amyotrophic lateral sclerosis and Parkinsonism-dementia on Guam and Rota, Am. J. Epidemiol., 125, 92-100 (1987).
18. M. W. Duncan, J. C. Steele, I. J. Kopin, and S. P. Markey, 2-Amino-3-(methylamino)-propanoic acid (BMAA) in cycad flour: An unlikely cause of amyotrophic lateral sclerosis and parkinsonism-dementia of Guam, Neurology, 40, 767-772 (1990).
19. G. E. Kisby, M. Ellison, and P. S. Spencer, Content of the neurotoxins cycasin (methylazoxymethanol β-D-glucoside) and BMAA (β-N-methylamino-L-alanine) in cycad flour prepared by Guam Chamorros, Neurology, 42, 1336-1340 (1992).
20. A. Kobayashi, Cycasin in cycad materials used in Japan, Fed. Proc., 31, 1476-1477 (1972).
21. Z. X. Zhang, D. W. Anderson, N. Mantel, and G. C. Roman, Motor neuron disease on Guam: Geographic and familial occurrence, 1956-85, Acta Neurol. Scand., 94, 51-59 (1996).
22. R. W. Hornabrook, Essays on Kuru, Classey, Farindgon, Berkshire, Classey, U.K., 1976.
23. F. H. Anderson, E. P. Richardson, H. Okazaki, and J. A. Brody, Neurofibrillary degeneration on Guam: Frequency in Chamorros and non Chamorros with no known neurological disease, Brain, 102, 65-77 (1975).
24. R. M. Garruto, D. C. Gadjusek, and K.-M. Chen, Amyotrophic lateral sclerosis among Chamorro migrants from Guam, Ann. Neurol., 8, 612-619 (1980).
25. Y. Yase, The pathogenesis of amyotrophic lateral sclerosis, Lancet, 2, 292-296 (1972).
26. H. Shiraki and Y. Yase, Amyotrophic lateral sclerosis in Japan, in Handbook of Clinical Neurology. Vol. 22. System Disorders and Atrophy, Part 2 (P. J. Vinken and G. W. Bruyn, eds.), American Elsevier, New York, 1975.
27. M. M. Jones, M. Yang, and O. Mickelsen, Effects of methylazoxymethanol glucoside and methylazoxymethanol acetate on the cerebellum of the postnatal Swiss albino mouse, Fed. Proc., 31, 1508-1511 (1972).
28. P. S. Spencer and G. E. Kisby, Slow toxins and western Pacific amyotrophic lateral sclerosis, in Handbook of Amyotrophic Lateral Sclerosis (R. A. Smith, ed.), Marcel Dekker, Inc., New York, 1992.
29. P. S. Spencer, G. E. Kisby, and A. C. Ludolph, Slow toxins, biologic markers, and long-latency neurodegenerative disease in the western Pacific region, Neurology, 41, 62-66 (1991).
30. G. E. Kisby, S. M. Ross, P. S. Spencer, B. G. Gold, P. B. Nunn, and D. N. Roy, Cycasin and BMAA: Candidate neurotoxins for western Pacific amyotrophic lateral sclerosis/Parkinsonism-dementia complex, Neurodegeneration, 1, 73-82 (1992).
31. P. S. Spencer, P. B. Nunn, J. Hugon, A. C. Ludolph, S. M. Ross, D. N. Roy, and R. C. Robertson, Guam amyotrophic lateral sclerosis-parkinsonism-dementia linked to a plant excitant neurotoxin, Science, 237, 517-522 (1987).
32. S. M. Ross and P. S. Spencer, Specific antagonism of behavioral action of "uncommon" amino acids linked to motor-system diseases, Synapse, 1, 248-253 (1987).
33. J. H. Weiss and D. W. Choi, β-N-Methylamino-L-alanine neurotoxicity: Requirement for bicarbonate as a cofactor, Science, 241, 973-975 (1988).
34. J. H. Weiss, J.-Y. Koh, and D. W. Choi, Neurotoxicity of β-N-methylamino-L-alanine (BMAA) and β-N-oxalylamino-L-alanine (BOAA) on cultured cortical neurons, Brain Res., 497, 64-71 (1989).
35. R. L. Albin, and T. Greenamyre, Alternative excitotoxic hypotheses, J. Am. Acad. Neurol., 42, 733-738 (1992).
36. C. N. Allen, S. M. Ross, and P. S. Spencer, Properties of neurotoxic non-protein amino acids, β-N-methylamino-L-alanine (BMAA) and β-N-oxalyl-amino-L-alanine (BOAA), in ALS, New Advances in Toxicology and Epidemiology (F. C. Rose and F. H. Norris, eds.), Smith Gordon, London, 1990.
37. A. Copani, P. L. Canonico, and F. Nicoletti, β-N-Methylamino-L-alanine (L-BMAA) is a potent agonist of "metabolotropic" glutamate receptors, Eur. J. Pharmacol., 181, 327-328 (1990).
38. G. E. Kisby, V. Nottingham, R. Kayton, D. N. Roy, and P. S. Spencer, Brain metabolism of β-N-methylamino-L-alanine (BMAA) and protection of excitotoxicity by GABA-uptake inhibitors, Soc. Neurosci. Abstr., 18, 82 (1992).
39. A. A. Seawright, A. W. Brown, C. C. Nolan, and J. B. Cavanagh, Selective degeneration of cerebellar cortical neurons caused by cycad neurotoxin, L-β-methylaminoalanine (L-BMAA), in rats, Neuropathol. Appl. Neurobiol., 16, 153-169 (1990).
40. T. L. Perry, C. Bergeron, A. J. Biro, and S. Hansen, β-N-Methylamino-L-alanine. Chronic oral administration is not neurotoxic to mice, J. Neurol. Sci., 94, 173-180 (1989).
41. M. W. Duncan, W. E. Villacreses, P. G. Pearson, L. Wyatt, S. I. Rapoport, I. Kopin, S. P. Markey, and Q. R. Smith, 2-Amino-3-(methylamino)-propanoic acid (BMAA) pharmacokinetics and blood-barrier permeability in the rat, J. Pharmacol. Exp. Ther., 258, 27-35 (1991).
42. Q. R. Smith, H. Nagura, Y. Takada, and M. W. Duncan, Facilitated transport of the neurotoxin, β-N-methylamino-L-alanine, across the blood-brain barrier, J. Neurochem., 58, 1330-1337 (1992).
43. J. F. Kabel, G. E. Kisby, S. C. Mako, R. H. Glew, and P. S. Spencer, Rodent brain metabolism of cycasin and DNA alkylation by methylazoxymethanol (MAM), Soc. Neurosci. Abstr., 18, 1249 (1992).
44. +-dependent and phlorizininhibitable transport of glucose and cycasin in brain endothelial cells, J. Neurochem., 70, 772-777 (1998).
45. T. Nishizaki, A. Kammesheidt, K. Sumikawa, T. Asada, and Y. Okada, A sodium-and energy-dependent glucose transporter with similarities to SGLT1-2 is expressed in bovine cortical vessels, Neurosci. Res., 22, 13-22 (1995).
46. +/glucose cotransporter, Biochim. Biophys. Acta, 1193, 151-154 (1994).
47. H. Matsumoto, Cycasin, in CRC Handbook of Naturally Occurring Food Toxicants (M. J. Rechcigl, ed.), CRC Press, Boca Raton, FL, 1985.
48. G. L. Laqueur and H. Matsumoto, Neoplasms in female Fischer rats following intraperitoneal injection of methylazoxymethanol, J. Natl. Cancer Inst., 124, 691-697 (1967).
49. G. L. Laqueur, O. Mickelson, M. G. Shitney, and L. T. Kurland, Carcinogenic properties of nuts from Cycas circinalls L. indigenous to Guam, J. Natl. Cancer Inst., 31, 919-959 (1963).
50. S. M. Sieber, P. Correa, D. W. Dalgard, K. R. McIntire, and R. H. Adamson, Carcinogenicity and hepatotoxicity of cycasin and its aglycone methylazoxymethanol acetate in nonhuman primates, J. Natl. Cancer Inst., 65, 177-189 (1980).
51. M. G. Yang, O. Mickelsen, and M. E. Campbell, Cycad flour used by Guamanians: Effects produced in rats by long-term feeding, J. Nutr., 90, 153-156 (1966).
52. T. Shimiuz, N. Yasuda, I. Kono, F. Yagi, K. Tadera, and A. Kobayashi, Hepatic and spinal lesions in goats chronically intoxicated with cycasin, Jpn. J. Vet. Sci., 8, 1291-1295 (1986).
53. D. K. Dastur, Cycad toxicity in monkeys: Clinical, pathological and biochemical aspects, Fed. Proc., 23, 1368-1369 (1964).
54. D. K. Dastur and R. S. Palekar, The experimental pathology of cycad toxicity with special reference to oncogenic effects, Indian J. Cancer, 2, 33-49 (1974).
55. M. G. Whiting, Toxicity of cycads, Econ. Bot., 17, 271-302 (1963).
56. M. M. Mason and T. N. Fredrickson, Derriengue investigations. The Fourth Conference on the Toxicity of Cycads, in Toxicity of Cycads: Implications for Neurodegenerative Disease and Cancer. Transcripts of Four Cycad Conferences (M. G. Whiting, ed.), Medical Research Foundation, New York, 1988.
57. P. T. Hooper, Cycad poisoning, in Handbook of Natural Toxins: Plant and Fungal Toxins (R. F. Keeler and A. T. Tu, eds.), Marcel Dekker, Inc., New York, 1983.
58. D. K. Dastur, R. S. Palekar, and D. K. Manghani, Toxicity of various forms of Cycas circinalis in rhesus monkeys - pathology of brain, spinal cord and liver, in ALS. New Advances in Toxicology and Epidemiology (F. C. Rose and F. H. Norris, eds.), Smith Gordon, London, 1990.
59. F. J. Garcia-Ladona, J. de Barry, C. Girard, and G. Gombos, Ectopic granule cell layer in mouse cerebellum after methylazoxymethanol (MAM) treatment, Exp. Brain Res., 86, 90-96 (1991).
60. M. H. Lee and A. Rabe, Premature decline in Morris water maze performance of aging microencephalic rats, Neurotoxicol. Teratol., 14, 383-392 (1992).
61. G. M. Ramakers, I. J. A. Urban, P. N. E. De Graan, M. Di Luca, F. Cattabeni, and W. H. Gispen, The impaired long-term potentiation in the CA1 field of the hippocampus of cognitive deficient microencephalic rats is restored by D-serine, Neuroscience, 54, 49-60 (1993).
62. G. E. Kisby, C. Sweatt, S. McEvoy, and P. S. Spencer, Potentiation of cycad toxin-induced DNA damage in brain tissue by DNA-repair inhibitors, Soc. Neurosci. Abstr., 20, 1649 (1994).
63. G. M. Williams and J. H. Weisburger, Chemical carcinogenesis, in Toxicology, The Basic Science of Poisons (C. T. Klassen, M. O. Amdur, and J. Doull, eds.), MacMillian, New York, 1986.
64. M. Cimino, F. Cattabeni, M. Di Luca, G. Peruzzi, M. Andena, P. Tirassa, F. Angelucci, C. Cozzari, and L. Aloe, Levels of NGF, p75NGFR and ChAT immunoreactivity in brain of adult and aged microencephalic rats, Neurobiol. Aging, 17, 137-142 (1996).
65. P. O. Greiner, C. M. Bonnet, D. Angignard, J. M. Dupont, M. Herold, and M. G. Borzeix, Neuropharmacological study of aged MAM-treated rats, Neurobiol. Aging, 13, 527-529 (1992).
66. M. H. Fischer, J. W. Herrn, and H. A. Waisman, A preliminary biochemical examination of microencephalic rat brains, Biochem. Pharmacol., 22, 267-271 (1973).
67. M. H. Fischer, C. Welker, and H. A. Waisman, Generalized growth retardation in rats induced by prenatal exposure to methylazoxymethyl acetate, Teratology, 5, 223-232 (1972).
68. W. Balduini, et al., Microencephalic rats as a model for cognitive disorders, Clin. Neuropharmacol., 9, S8-S18 (1986).
69. S. A. Ferguson, F. D. Racey, M. G. Paule, and R. R. Holson, Behavioral effects of methylazoxymethanol-induced microencephaly, Behav. Neurosci., 107, 1-10 (1993).
70. K. Gillies and D. J. Price, The fates of cells in the developing cerebral cortex of normal and methylazoxymethanol acetate-lesioned mice, Eur. J. Neurosci., 5, 73-84 (1993).
71. E. S. Goldey, J. P. O'Callaghan, M. E. Stanton, S. Barone, Jr., and K. M. Crofton, Developmental neurotoxicity: Evaluation of testing procedures with methylazoxymethanol and methylmercury, Fundam. Appl. Toxicol., 23, 447-464 (1994).
72. E. Cattaneo, B. Reinach, A. Caputi, F. Cattabeni, and M. Di Luca, Selective in vitro blockade of neuroepithelial cell proliferation by methylazoxymethanol, a molecule capable of inducing long lasting functional impairments, J. Neurosci. Res., 41, 640-647 (1995).
73. M. V. Johnston and J. T. Coyle, Histological and neurochemical effects of fetal treatment with methylazoxymethanol on rat neocortex in adult-hood, Brain Res., 170, 135-155 (1979).
74. M. V. Johnston and J. T. Coyle, Ontogeny of neurochemical markers for noradrenergic, GABAergic and cholinergic neurons in neocortex lesioned with methylazoxymethanol acetate, J. Neurochem., 34, 1429-1441 (1980).
75. M. Eriksdotter-Nilsson, G. Jonsson, D. Dahl, and H. Bjorklund, Astroglial development in microencephalic rat brain after fetal methylazoxymethanol treatment, J. Dev. Neurosci., 4, 353-362 (1986).
76. J. R. Hoffman, L. J. Boyne, P. Levitt, and I. Fischer, Short exposure of methylazoxymethanol causes a long-term inhibition of axonal outgrowth from cultured embryonic rat hippocampal neurons, J. Neurosci. Res., 46, 349-359 (1996).
77. F. Esclaire, G. E. Kisby, J. Milne, M. Lesort, P. Spencer, and J. Hugon, The Guam cycad toxin methylazoxymethanol damages neuronal DNA and modulates tau mRNA expression and excitotoxicity, Exp. Neurol., 155, 11-21 (1999).
78. E. Mullaart, M. E. T. I. Boerrigter, G. J. Boer, and J. Vijg, Spontaneous DNA breaks in the rat brain during development and aging, Mutat. Res., 257, 9-15 (1990).
79. E. Mullaart, M. E. T. I. Boerrigter, A. Brouwer, F. Berends, and J. Vijg, Age-dependent accumulation of alkali-labile sites in DNA of post-mitotic but not in that of mitotic rat liver cells, Mech. Ageing Dev., 45, 41-49 (1988).
80. M. S. Bhaskar and K. S. Rao, Altered conformation and increased strand breaks in neuronal and astroglial DNA of aging rat brain, Biochem. Mol. Biol. Int., 33, 377-384 (1994).
81. B. S. Mandavilli and K. S. Rao, Neurons in the cerebral cortex are most susceptible to DNA-damage in aging rat brain, Biochem. Mol. Biol. Int., 40, 507-514 (1996).
82. B. S. Mandavilli and K. S. Rao, Accumulation of DNA damage in aging neurons occurs through a mechanism other than apoptosis, J. Neurochem., 67, 1559-1565 (1996).
83. P. Mecocci, U. MacGarvey, A. E. Kaufman, D. Koontz, J. M. Shoffner, D. C. Wallace, and M. F. Beal, Oxidative damage to mitochondrial DNA shows marked age-dependent increases in human brain, Ann. Neurol., 34, 609-616 (1993).
84. P. S. Fitzmaurice, I. C. Shaw, H. E. Kleiner, R. T. Miller, T. J. Monks, S. S. Lau, J. D. Mitchell, and P. G. Lynch, Evidence for DNA damage in amyotrophic lateral sclerosis, Muscle Nerve, 19, 797-798 (1996).
85. R. J. Ferrante, S. E. Browne, L. A. Shinobu, A. C. Bowling, M. J. Baik, U. MacGarvey, N. W. Kowall, R. H. Brown, Jr., and M. F. Beal, Evidence of increased oxidative damage in both sporadic and familial amyotrophic lateral sclerosis, J. Neurochem., 69, 2064-2074 (1997).
86. J. R. Sanchez-Ramos, E. Övervik, and B. N. Ames, A marker of oxyradical-mediated DNA damage (8-hydroxy-2′-deoxyguanosine) is increased in nigro-striatum of Parkinson's disease brain, Neurodegeneration, 3, 197-204 (1994).
87. Z. I. Alam, A. Jenner, S. E. Daniel, A. J. Lees, N. Cairns, C. D. Marsden, P. Jenner, and B. Halliwell, Oxidative DNA damage in the Parkinsonian brain: An apparent selective increase in 8-hydroxyguanine levels in substantia nigra, J. Neurochem., 69, 1196-1203 (1997).
88. P. Mecocci, U. MacGarvey, and M. F. Beal, Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease, Ann. Neurol., 36, 747-751 (1994).
89. L. Lyras, N. J. Cairns, A. Jenner, P. Jenner, and B. Halliwell, An assessment of oxidative damage to proteins, lipids, and DNA in brain from patients with Alzheimer's disease, J. Neurochem., 68, 2061-2069 (1997).
90. S. P. Gabbita, M. A. Lovell, and W. R. Markesbery, Increased nuclear DNA oxidation in the brain in Alzheimer's disease, J. Neurochem., 71, 2034-2040 (1998).
91. 6-methylguanine-DNA methyltransferase activity and its depletion after carcinogen treatment in the teleost medaka (Oryzias latopes), Mutat. Res., 293, 225-231 (1993).
92. M. Cavanna, S. Parodi, M. Taningher, C. Bolognesi, L. Sciaba, and G. Brambilla, DNA fragmentation in some organs of rats and mice treated with cycasin, Br. J. Cancer, 39, 383-389 (1979).
93. I. Damjanov, R. Cox, D. S. R. Sarma, and E. Farber, Patterns of damage and repair of liver DNA induced by carcinogenic methylating agents in vivo, Cancer Res., 33, 2122-2128 (1973).
94. C. Kidson, P. Chen, F. P. Imray, and E. Gipps, Nervous system disease associated with dominant cellular radiosensitivity, in Cellular Responses to DNA Damage (E. C. Friedberg and B. A. Bridges, eds.), Alan R. Liss, Inc., New York, 1983.
95. J. H. Robbins, Hypersensitivity to DNA-damaging agents in primary degenerations of excitable tissue, in Cellular Responses to DNA Damage (E. C. Friedberg and B. A. Bridges, eds.), Alan R. Liss, Inc., New York, 1983.
96. A. M. R. Taylor, D. G. Harnden, C. F. Arlett, S. A. Harcourt, A. R. Lehmann, S. Stevens, and B. A. Bridges, Ataxia-telangiectasia: A human mutation with abnormal radiation sensitivity, Nature, 258, 427-429 (1975).
97. B. H. Tan, A. Bencsath, and J. W. Gaubatz, Steady-state levels of 7-methylguanine increase in nuclear DNA of postmitotic mouse tissues during aging, Mutat. Res., 237, 229-238 (1990).
98. H. Matsumoto, M. Spatz, and G. L. Laqueur, Quantitative changes with age in the DNA content of methylazoxymethanol-induced microencephalic rat brain, J. Neurochem., 19, 297-306 (1972).
99. C. Richter, J. W. Park, and B. N. Ames, Normal oxidative damage to mitochondrial and nuclear DNA is extensive, Proc. Natl. Acad. Sci. USA, 85, 6456-6467 (1988).
100. I. Ferrer, E. Pozas, M. Marti, R. Blanco, and A. M. Planas, Methylazoxymethanol acetate-induced apoptosis in the external granule cell layer of the developing cerebellum of the rat is associated with strong c-Jun expression and formation of high molecular weight c-Jun complexes, Neuropathol. Exp. Neurol., 56, 1-9 (1997).
101. I. Ferrer, E. Pozas, and A. M. Planas, Ubiquitination of apoptotic cells in the developing cerebellum of the rat following ionizing radiation or methylazoxymethanol injection, Acta Neuropathol., 93, 402-407 (1997).
102. M. Lafarga, A. Lerga, M. A. Andres, J. I. Polanco, E. Calle, and M. T. Berciano, Apoptosis induced by methylazoxymethanol in developing rat cerebellum: Organization of the cell nucleus and its relationship to DNA and rRNA degradation, Cell Tissue Res., 289, 25-38 (1997).
103. K. A. Wood and R. J. Youle, The role of free radicals and p53 in neuron apoptosis in vivo, J. Neurosci., 15, 5851-5857 (1995).
104. H. W. Van Den Berg and C. R. Ball, The effect of methylazoxymethanol acetate on DNA synthesis and cell proliferation of synchronous HeLa cells, Mutat. Res., 16, 381-390 (1972).
105. A. J. Bedford, E. H. Cooper, and T. E. Kenny, A kinetic analysis of death and survival in HeLa cells following exposure to methylazoxymethanol acetate, Eur. J. Cancer, 10, 713-720 (1974).
106. Y. Nagata and H. Matsumoto, Studies on methylazoxymethanol: Methylation of nucleic acids in the fetal rat brain, Proc. Soc. Exp. Biol. Med., 132, 383-385 (1969).
107. H. Matsumoto and H. H. Higa, Studies on methylazoxymethanol, the aglycone of cycasin: Methylation of nucleic acids in vitro, Biochem. J., 98, 20C-22C (1966).
108. 2O, Nature, 236, 234-235 (1972).
109. G. E. Kisby, B. G. Gold, D. R. Austin, B. Lystrup, and P. S. Spencer, DNA damage in rodent brain tissue induced by cycad toxins, Soc. Neurosci. Abstr., 19, 196 (1993).
110. G. E. Kisby, D. Eizirik, C. Sweatt, and P. S. Spencer, Reactive oxygen species produced by the cycad toxin methylazoxymethanol, a candidate etiological factor for western Pacific ALS/P-D, J. Cell Biochem., 21B, 99 (1995).
111. O. Augusto, L. E. S. Netto, and L. F. Gomes, DNA alkylation by carbon-centered radicals, Braz. J. Med. Biol. Res., 25, 1171-1183 (1992).
112. E. Seeberg, L. Eide, and M. Bjoras, The base excision repair pathway, Trends Biochem. Sci., 20, 391-397 (1995).
113. 6-alkylguanine-DNA alkyltransferase, Prog. Nucleic Acid Res. Mol. Biol., 51, 167-223 (1995).
114. 6-methylguanine acceptor protein in tissues of rats and their relationship to carcinogenicity and aging, J. Natl. Cancer Inst., 75, 1141-1145 (1985).
115. 6-alkylguanine-DNA alkyltransferase activity in human brain and brain tumors, Carcinogenesis, 5, 121-124 (1984).
116. T. M. Wilson, S. A. Rivkees, W. A. Deutsch, and M. R. Kelley, Differential expression of the apurinic/apyrimidinic endonuclease (APE/ref-1) multifunctional DNA base excision repair gene during fetal development and in adult rat brain and testis, Mutat. Res., 362, 237-248 (1996).
117. J. R. Duguid, J. N. Eble, T. M. Wilson, and M. R. Kelley, Differential cellular and subcellular expression of the human multifunctional apurinic/ apyrimidinic endonuclease (APE/ref-1) DNA repair enzyme, Cancer Res., 55, 6097-6102 (1995).
118. 6-methylguanine-DNA methyltransferase in histologically normal brain adjacent to primary human brain tumors, Proc. Natl. Acad. Sci. USA, 93, 6941-6946 (1996).
119. 6-methylguanine-DNA methyltransferase activity in brain tumors and adjacent normal brain, Cancer Res., 53, 3416-3420 (1993).
120. Y. Ono, M. Watanabe, Y. Inoue, T. Ohmoto, K. Akiyama, K. Tsutsui, and S. Seki, Developmental expression of APEX nuclease, a multifunctional DNA repair enzyme, in mouse brains, Dev. Brain Res., 86, 1-6 (1995).
121. M. Edwards, D. K. Rassin, T. Izumi, S. Mitra, and J. R. Perez-Polo, APE/ Ref-1 responses to oxidative stress in aged rats, J. Neurosci. Res., 54, 635-638 (1998).
122. 6-methylguanine-DNA methyltransferase in human fetal tissues: Fetal and maternal factors, Cancer Res., 47, 51-55 (1987).
123. T. Grombacher, S. Mitra, and B. Kaina, Induction of the alkyltransferase (MGMT) gene by DNA damaging agents and the glucocorticoid dexamethasone and comparison with the response of base excision repair genes, Carcinogenesis, 17, 2329-2336 (1996).
124. M. Walton, P. Lawlor, E. Sirimanne, C. Williams, P. Gluckman, and M. Dragunow, Loss of Ref-1 protein expression precedes DNA fragmentation in apoptotic neurons, Mol. Brain Res., 44, 167-170 (1997).
125. H. Fung, Y. W. Kow, B. Van Houten, D. J. Taatjes, Z. Hatahet, Y. M. W. Janssen, P. Vacek, S. P. Faux, and B. T. Mossman, Asbestos increases mammalian AP-endonuclease gene expression, protein levels, and enzyme activity in mesothelial cells, Cancer Res., 58, 189-194 (1998).
126. C. V. Ramana, I. Boldogh, T. Izumi, and S. Mitra, Activation of apurinic/ apyrimidinic endonuclease in human cells by reactive oxygen species and its correlation with their adaptive response to genotoxicity of free radicals, Proc. Natl. Acad. Sci. USA, 95, 5061-5066 (1998).
127. H. Korr and B. Schultz, Unscheduled DNA synthesis in various types of cells of the mouse brain in vivo, Exp. Brain Res., 74, 573-578 (1989).
128. 6-methylguanine, Cancer Res., 56, 5615-5619 (1996).
129. G. E. Kisby, J. Milne, J. G. Hugon, M. Lesort, F. Esclaire, and P. S. Spencer, Methylazoxymethanol (MAM), a candidate etiological factor for Guam ALS, damages rat brain DNA and modulates its repair, Soc. Neurosci. Abstr., 22, 2141 (1996).
130. G. E. Kisby, N. Springer, and P. S. Spencer, In vitro neurotoxic and DNA-damage properties of nitrogen mustard (HN2), J. Appl. Toxicol. (in press).
131. D. L. Eizirik and G. E. Kisby, Cycad toxin-induced damage of rodent and human pancreatic β-islet cells, Biochem. Pharmacol., 50, 355-365 (1995).
132. G. E. Kisby, N. Springer, A. Claus, M. Turker, and P. S. Spencer, DNA damage, neurodegeneration and motor neuron disease, Soc. Neurosci. Abstr., 23, 215 (1997).
133. V. M. Y. Lee and J. Q. Trojanowski, Tau proteins and their significance in the pathobiology of Alzheimer's disease, in Pathobiology of Alzheimer's Disease (A. M. Goate and F. Ashall, eds.), Academic Press Ltd, London, 1995.
134. P. R. Hof, E. A. Nimchinsky, V. Bueé-Scherrer, L. Bueé, J. Nasrallah, A. F. Hottinger, D. P. Purohit, A. J. Loerzel, J. C. Steele, A. Delacourte, C. Bouras, J. H. Morrison, and D. P. Perl, Amyotrophic lateral sclerosis/ parkinsonism-dementia complex of Guam: Quantitative neuropathology, immunohistochemical analysis of neuronal vulnerability, and comparison with related neurodegenerative disorders, Acta Neuropathol., 88, 397-404 (1994).
135. M. Mawal-Dewan, M. L. Schmidt, B. Balin, D. P. Perl, V. M. Y. Lee, and J. Q. Trojanowski, Identification of phosphorylation sites in PHF-tau from patients with Guam amyotrophic lateral sclerosis/parkinsonism-dementia complex, J. Neuropathol. Exp. Neurol., 55, 1051-1059 (1996).
136. V. Buée-Scherrer, L. Buée, P. R. Hof, B. Leveugle, C. Gilles, A. J. Loerzel, D. P. Perl, and A. Delacourte, Neurofibrillary degeneration in amyotrophic lateral sclerosis/parkinsonism-dementia complex of Guam - Immunochemical characterization of tau proteins, Am. J. Pathol., 146, 924-932 (1995).
137. H. L. Gensler and H. Bernstein, DNA damge as the primary cause of aging, Quart. Rev. Biol., 56, 279-303 (1981).
138. P. C. Hanawalt and A. Sarasin, Cancer-prone hereditary diseases with DNA processing abnormalities, Trends Genet., 2, 124-128 (1986).
139. K. S. Rao and L. A. Loeb, DNA damage and repair in brain: Relationship to aging, Mutat. Res., 275, 317-329 (1992).
140. Z. L. Olkowski and J. Rosenfeld, Abnormal DNA repair in patients with ALS, Soc. Neurosci. Abstr., 21, 1005 (1995).
141. Z. L. Olkowski, Mutant AP endonuclease in patients with amyotrophic lateral sclerosis, NeuroReport, 9, 239-242 (1998).
142. G. E. Kisby, J. Milne, and C. Sweatt, Evidence of reduced DNA repair in amyotrophic lateral sclerosis brain tissue, NeuroReport, 8, 1337-1340 (1997).
143. Z. Tan, N. Sun, and S. S. Schreiber, Immunohistochemical localization of redox factor-1 (Ref-1) in Alzheimer's hippocampus, NeuroReport, 9, 2749-2752 (1998).
144. G. E. Kisby, C. Sweatt, and P. S. Spencer, Evidence of reduced brain tissue DNA repair in neurodegenerative disease, Soc. Neurosci. Abstr., 27, 484 (1995).
145. N. S. Raji and K. S. Rao, Trisomy 21 and accelerated aging: DNA-repair parameters in peripheral lymphocytes of Down's syndrome patients, Mech. Ageing Dev., 100, 85-101 (1998).
146. N. Druzhyna, R. G. Nair, S. P. LeDoux, and G. L. Wilson, Defective repair of oxidative damage in mitochondrial DNA in Down's syndrome, Mutat. Res., 409, 81-89 (1998).
147. G. E. Kisby, C. Sweatt, and P. S. Spencer, Role of DNA repair in protecting mature nervous tissue from DNA damage, J. Cell Biochem., 21A, 348 (1995).
148. B. Demple and L. Harrison, Repair of oxidative damage to DNA: Enzymology and biology, Annu. Rev. Biochem., 63, 915-948 (1994).
149. L. B. Daniels and R. H. Glew, β-Glucosidase assays in the diagnosis of Gaucher's disease, Clin. Chem., 28, 569-577 (1982).